- Jun 05, 2014
Paolo Cifani is selected as American-Italian Cancer Foundation Fellow
Congratulations to Paolo for being selected as American-Italian Cancer Foundation Fellow! For more than 30 years, AICF has supported both improved patient care and innovative cancer research, and we are grateful for their recognition and support of Paolo’s work.
Twitter FeedLoad More...
Sometimes it’s important to publish your results when the data doesn’t turn out how you hoped. Here’s our paper evaluating the quantitative consequences of using a protein carrier in two low-input applications: pMHC and pTyr…
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
How do DNA-binding proteins engage specific sites “hidden” in chromatin? Recent cryoEM studies shed light on mechanisms @KurumizakaLab @CramerLab TaipaleLab, @SchubelerLab @LabThoma
Proteomics folks, we are trying to look for mass spectral evidence of branched peptides, where fragment spectra may content a large lysine adduct and many will be chimeric from co-fragmentation of branches. 1/n
Finally out in @NatureComms, the validation and clinical experience of our plasma-based assay #MSKaccess
https://rdcu.be/cmMyf. Thank you, my wonderful colleagues for the journey and reviewer #2 for making us more resilient, one question at a time...